Hydroxytyrosol: A Promising Therapeutic Agent for Mitigating Inflammation and Apoptosis

Inflammation and apoptosis are interrelated biological processes that have a significant impact on the advancement and growth of certain chronic diseases, such as cardiovascular problems, neurological conditions, and osteoarthritis. Recent research has emphasized that focusing on these mechanisms co...

Full description

Saved in:
Bibliographic Details
Main Authors: Wafa Ali Batarfi, Mohd Heikal Mohd Yunus, Adila A. Hamid, Yi Ting Lee, Manira Maarof
Format: Article
Language:English
Published: MDPI AG 2024-11-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/16/12/1504
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846103220665974784
author Wafa Ali Batarfi
Mohd Heikal Mohd Yunus
Adila A. Hamid
Yi Ting Lee
Manira Maarof
author_facet Wafa Ali Batarfi
Mohd Heikal Mohd Yunus
Adila A. Hamid
Yi Ting Lee
Manira Maarof
author_sort Wafa Ali Batarfi
collection DOAJ
description Inflammation and apoptosis are interrelated biological processes that have a significant impact on the advancement and growth of certain chronic diseases, such as cardiovascular problems, neurological conditions, and osteoarthritis. Recent research has emphasized that focusing on these mechanisms could result in novel therapeutic approaches that aim to decrease the severity of diseases and enhance patient outcomes. Hydroxytyrosol (HT), which is well-known for its ability to prevent oxidation, has been identified as a possible candidate for regulating both inflammation and apoptosis. In this review, we will highlight the multifaceted benefits of HT as a therapeutic agent in mitigating inflammation, apoptosis, and associated conditions. This review provides a comprehensive overview of the latest in vitro and in vivo research on the anti-inflammatory and antiapoptotic effects of HT and the mechanisms by which it works. Based on these studies, it is strongly advised to use HT as a bioactive ingredient in pharmaceutical products intended for mitigating inflammation, as well as those with apoptosis applications.
format Article
id doaj-art-5591fbcdbc9b4eac862d2bc34dd9bce3
institution Kabale University
issn 1999-4923
language English
publishDate 2024-11-01
publisher MDPI AG
record_format Article
series Pharmaceutics
spelling doaj-art-5591fbcdbc9b4eac862d2bc34dd9bce32024-12-27T14:46:19ZengMDPI AGPharmaceutics1999-49232024-11-011612150410.3390/pharmaceutics16121504Hydroxytyrosol: A Promising Therapeutic Agent for Mitigating Inflammation and ApoptosisWafa Ali Batarfi0Mohd Heikal Mohd Yunus1Adila A. Hamid2Yi Ting Lee3Manira Maarof4Department of Physiology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Jalan Yaacob Latiff, Bandar Tun Razak, Kuala Lumpur 56000, MalaysiaDepartment of Physiology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Jalan Yaacob Latiff, Bandar Tun Razak, Kuala Lumpur 56000, MalaysiaDepartment of Physiology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Jalan Yaacob Latiff, Bandar Tun Razak, Kuala Lumpur 56000, MalaysiaDepartment of Physiology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Jalan Yaacob Latiff, Bandar Tun Razak, Kuala Lumpur 56000, MalaysiaDepartment of Tissue Engineering and Regenerative Medicine, Faculty of Medicine, Universiti Kebangsaan Malaysia, Jalan Yaacob Latiff, Bandar Tun Razak, Kuala Lumpur 56000, MalaysiaInflammation and apoptosis are interrelated biological processes that have a significant impact on the advancement and growth of certain chronic diseases, such as cardiovascular problems, neurological conditions, and osteoarthritis. Recent research has emphasized that focusing on these mechanisms could result in novel therapeutic approaches that aim to decrease the severity of diseases and enhance patient outcomes. Hydroxytyrosol (HT), which is well-known for its ability to prevent oxidation, has been identified as a possible candidate for regulating both inflammation and apoptosis. In this review, we will highlight the multifaceted benefits of HT as a therapeutic agent in mitigating inflammation, apoptosis, and associated conditions. This review provides a comprehensive overview of the latest in vitro and in vivo research on the anti-inflammatory and antiapoptotic effects of HT and the mechanisms by which it works. Based on these studies, it is strongly advised to use HT as a bioactive ingredient in pharmaceutical products intended for mitigating inflammation, as well as those with apoptosis applications.https://www.mdpi.com/1999-4923/16/12/1504hydroxytyrosolinflammationapoptosisnatural products
spellingShingle Wafa Ali Batarfi
Mohd Heikal Mohd Yunus
Adila A. Hamid
Yi Ting Lee
Manira Maarof
Hydroxytyrosol: A Promising Therapeutic Agent for Mitigating Inflammation and Apoptosis
Pharmaceutics
hydroxytyrosol
inflammation
apoptosis
natural products
title Hydroxytyrosol: A Promising Therapeutic Agent for Mitigating Inflammation and Apoptosis
title_full Hydroxytyrosol: A Promising Therapeutic Agent for Mitigating Inflammation and Apoptosis
title_fullStr Hydroxytyrosol: A Promising Therapeutic Agent for Mitigating Inflammation and Apoptosis
title_full_unstemmed Hydroxytyrosol: A Promising Therapeutic Agent for Mitigating Inflammation and Apoptosis
title_short Hydroxytyrosol: A Promising Therapeutic Agent for Mitigating Inflammation and Apoptosis
title_sort hydroxytyrosol a promising therapeutic agent for mitigating inflammation and apoptosis
topic hydroxytyrosol
inflammation
apoptosis
natural products
url https://www.mdpi.com/1999-4923/16/12/1504
work_keys_str_mv AT wafaalibatarfi hydroxytyrosolapromisingtherapeuticagentformitigatinginflammationandapoptosis
AT mohdheikalmohdyunus hydroxytyrosolapromisingtherapeuticagentformitigatinginflammationandapoptosis
AT adilaahamid hydroxytyrosolapromisingtherapeuticagentformitigatinginflammationandapoptosis
AT yitinglee hydroxytyrosolapromisingtherapeuticagentformitigatinginflammationandapoptosis
AT maniramaarof hydroxytyrosolapromisingtherapeuticagentformitigatinginflammationandapoptosis